Latest Survival news
ACS Report: Five-Year Relative Survival Rates for All Cancers Up to 70 Percent in the U.S.
posted January 13th
by modernClinician Editorial Team
by modernClinician Editorial Team
Benefit of Retention on MOUD Treatment Lasts for at Least Four Years
posted January 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
New Tool Assesses Recurrence Risk With Pancreatic Neuroendocrine Tumors
posted December 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Intensity-Modulated Proton Therapy Noninferior to IMRT for Oropharyngeal Cancer
posted December 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
All-Cause Mortality Elevated for Adult Five-Year Survivors of Hodgkin Lymphoma 
Aircrew Face Higher Odds of Radiation-Related Cancer Deaths 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors Related Articles
Achieving PSA <0.2 ng/mL Improves Survival in Metastatic Castration-Sensitive Prostate Cancer 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine 
Recurrence Score Elevated for Breast Cancer Diagnosed Within First Year Postpartum 
Lung Transplant Can Prolong Survival in Stage IV NSCLC Monthly Specialist Briefings
Stay Connected
